BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29900587)

  • 1. Varices on computed tomography are surrogate of clinically significant portal hypertension and can predict survival in compensated cirrhosis patients.
    Lee DH; Ahn JH; Chung JW; Kim YJ; Cha SW; Kim MY; Baik SK
    J Gastroenterol Hepatol; 2019 Feb; 34(2):450-457. PubMed ID: 29900587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varices on computed tomography as predictor of survival after hepatic resection in patients with single hepatocellular carcinoma.
    Lee DH; Chung JW; Joo I; Suh KS; Kim SH; Koh YH; Lee JH; Cho YK; Park JW
    J Gastroenterol Hepatol; 2021 Jan; 36(1):225-232. PubMed ID: 32453898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient].
    Jiang FR; Yan HD
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):995-1000. PubMed ID: 34814395
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension.
    Berzigotti A; Rossi V; Tiani C; Pierpaoli L; Zappoli P; Riili A; Serra C; Andreone P; Morelli MC; Golfieri R; Rossi C; Magalotti D; Zoli M
    J Gastroenterol; 2011 May; 46(5):687-95. PubMed ID: 21213113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.
    Lens S; Alvarado-Tapias E; Mariño Z; Londoño MC; LLop E; Martinez J; Fortea JI; Ibañez L; Ariza X; Baiges A; Gallego A; Bañares R; Puente A; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; Forns X; García-Pagán JC
    Gastroenterology; 2017 Nov; 153(5):1273-1283.e1. PubMed ID: 28734831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
    Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
    Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Liver and Spleen Stiffness with Acoustic Radiation Force Impulse Quantification Elastography for Diagnosing Clinically Significant Portal Hypertension.
    Attia D; Schoenemeier B; Rodt T; Negm AA; Lenzen H; Lankisch TO; Manns M; Gebel M; Potthoff A
    Ultraschall Med; 2015 Dec; 36(6):603-10. PubMed ID: 26565516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.
    Gelman S; Salteniene V; Pranculis A; Skieceviciene J; Zykus R; Petrauskas D; Kupcinskas L; Canbay A; Link A; Kupcinskas J
    World J Gastroenterol; 2019 Jun; 25(23):2935-2946. PubMed ID: 31249451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.
    Villanueva C; Albillos A; Genescà J; Abraldes JG; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Garcia-Pagan JC; Pavel O; Bosch J
    Hepatology; 2016 Jan; 63(1):197-206. PubMed ID: 26422126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis.
    Lisotti A; Azzaroli F; Buonfiglioli F; Montagnani M; Cecinato P; Turco L; Calvanese C; Simoni P; Guardigli M; Arena R; Cucchetti A; Colecchia A; Festi D; Golfieri R; Mazzella G
    Hepatology; 2014 Feb; 59(2):643-50. PubMed ID: 24038116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India.
    Kumar A; Khan NM; Anikhindi SA; Sharma P; Bansal N; Singla V; Arora A
    World J Gastroenterol; 2017 Jan; 23(4):687-696. PubMed ID: 28216976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications.
    Kitson MT; Roberts SK; Colman JC; Paul E; Button P; Kemp W
    Scand J Gastroenterol; 2015 Apr; 50(4):462-9. PubMed ID: 25623641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices.
    Lee E; Kim YJ; Goo DE; Yang SB; Kim HJ; Jang JY; Jeong SW
    World J Gastroenterol; 2016 Mar; 22(11):3212-9. PubMed ID: 27003998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.
    Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L
    World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.
    Augustin S; Millán L; González A; Martell M; Gelabert A; Segarra A; Serres X; Esteban R; Genescà J
    J Hepatol; 2014 Mar; 60(3):561-9. PubMed ID: 24211744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of portal hypertension and varices by acoustic radiation force impulse imaging of the liver compared to transient elastography and AST to platelet ratio index.
    Salzl P; Reiberger T; Ferlitsch M; Payer BA; Schwengerer B; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Ultraschall Med; 2014 Dec; 35(6):528-33. PubMed ID: 24871695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis.
    Kim MY; Suk KT; Baik SK; Kim HA; Kim YJ; Cha SH; Kwak HR; Cho MY; Park HJ; Jeon HK; Park SY; Kim BR; Hong JH; Jo KW; Kim JW; Kim HS; Kwon SO; Chang SJ; Baik GH; Kim DJ
    Hepatology; 2012 Sep; 56(3):1053-62. PubMed ID: 22473911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.